Poly Medicure Ltd.
NSE: POLYMED | BSE: 531768
₹1,532.40
As on 12-Jun-2026IST
Market cap
₹15,520 Cr
Revenue (TTM)
₹1,875 Cr
P/E Ratio
48.2
P/B Ratio
5
Div. Yield
0.2 %
Quality Score
7/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
2/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹322 Cr
-
ROE
16 %
-
ROCE
20.4 %
-
Industry P/E
106.79
-
EV/EBITDA
28
-
Debt to Equity
0
-
Book Value
₹306.5
-
EPS
₹32.3
-
Face value
5
-
Shares outstanding
101,359,490
10 Years Aggregate
CFO
₹1,368.77 Cr
EBITDA
₹2,114.61 Cr
Net Profit
₹1,392.95 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Poly Medicure
| -13.6 | -7.2 | 14.9 | -32.3 | 15.8 | 9.7 | 24.4 |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Poly Medicure
| -33.8 | 78.0 | 65.9 | -6.3 | 88.1 | 132.9 | -2.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
1,532.4 | 15,519.7 | 1,875.3 | 315.1 | 17.4 | 10.9 | 48.2 | 5.0 |
| 270.9 | 154.9 | 34.4 | -4.3 | -9.6 | -28.9 | -- | 13.8 | |
| 2,262.2 | 37,299.0 | 6,430.7 | 1,027.3 | 18.8 | 10.5 | 36.3 | 3.6 | |
| 226.7 | 1,242.1 | 277.9 | 26.4 | 9.9 | 8.3 | 42.9 | 5.1 | |
| 138.6 | 76.3 | 39.4 | 7.3 | 18.1 | 19.2 | 10.5 | 1.8 | |
| 882.0 | 10,596.7 | 6,892.5 | 219.6 | 4.7 | 11.5 | 48.2 | 5.4 | |
| 232.1 | 222.3 | 147.0 | 2.1 | -1.2 | 1.1 | 106.8 | 1.2 | |
| 95.3 | 184.3 | 172.9 | 11.9 | 12.7 | 9.7 | 18.2 | -- | |
| 73.5 | 120.7 | 80.0 | 1.9 | 12.2 | 4.9 | 66.7 | 2.6 | |
| 205.4 | 1,092.3 | 422.5 | 14.3 | 5.1 | 2.4 | 76.3 | 1.7 |
Shareholding Pattern
View DetailsNews & Analysis
All News1 min read•By Research Desk
About Poly Medicure
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged... infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India. Read more
-
Incorporated
1995
-
Chairman
Devendra Mehta
-
Managing Director
Himanshu Baid
-
Headquarters
New Delhi, Delhi
-
Website
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Of Investor/Analyst Meet
12-Jun-2026Investors/Analysts Meet Schedule
10-Jun-2026Intimation Of Analyst/Investor Meet
03-Jun-2026Intimation For The Analyst/Investors Meet
02-Jun-2026No News & Announcements are available.
FAQs for Poly Medicure
What is the current share price of Poly Medicure Ltd Today?
The share price of Poly Medicure Ltd is ₹1,532.40 (NSE) and ₹1,531.15 (BSE) as of 12-Jun-2026 IST. Poly Medicure Ltd has given a return of 15.8% in the last 3 years.
What is the current PB & PE ratio of Poly Medicure Ltd?
The P/E ratio of Poly Medicure Ltd is 48.18 times as on 12-Jun-2026, a 55 discount to its peers’ median range of 106.79 times.
The P/B ratio of Poly Medicure Ltd is 5.00 times as on 12-Jun-2026, a 64 discount to its peers’ median range of 13.77 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
67.10
|
8.22
|
|
2024
|
59.04
|
10.40
|
|
2023
|
51.01
|
7.38
|
|
2022
|
62.11
|
8.38
|
|
2021
|
57.69
|
8.13
|
What is the 52 Week High and Low of Poly Medicure Ltd?
The 52-week high and low of Poly Medicure Ltd are Rs 2,316.60 and Rs 1,182.00 as of 13-Jun-2026.
What is the market cap of Poly Medicure Ltd?
Poly Medicure Ltd has a market capitalisation of ₹ 15,520 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Poly Medicure Ltd?
Before investing in Poly Medicure Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
